Jonny Peter - Concepedia

Author

Jonny Peter

Also Known As

Ahmed Ismail Manjra, David S. Perlin, Eduan Deetlefs, J G Peter, J Hencil Peter, J PETER, J Peter, J Peters, J Tel, J. G. Peter

313

Publications

10.2K

Citations

H-Index

Concepts

All Affiliations

University of Cape Town Groote Schuur Hospital South African Tuberculosis Vaccine Initiative Stellenbosch University Charité - Universitätsmedizin Berlin

About

Jonny Peter is an author at University of Cape Town specializing in medicine, tuberculosis, and preventive treatment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.2K
2	Public Health	3	3	69
3	Allergy	3	3	119
4	Allergy Medicine	2	2	87
5	Health Sciences	1	1	64

Jonny Peter

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa Andrew Boulle, Mary‐Ann Davies, Hannah Hussey, Clinical Infectious Diseases	2020	593
Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial Grant Theron, Lynn S. Zijenah, Duncan Chanda, The Lancet Point-of-care Xpert Mtb/rifPulmonary TuberculosisPrimary CarePoint-of-care TestingTuberculosis Prevention	2013	437
Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting Grant Theron, Jonny Peter, Richard N. van Zyl-Smit, American Journal of Respiratory and Critical Care Medicine	2011	308
Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial Jonny Peter, Lynn S. Zijenah, Duncan Chanda, The Lancet Pulmonary TuberculosisTreatment And PreventionMedicineHiv-positive Hospital InpatientsTuberculosis Prevention	2016	262
Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings? Grant Theron, Jonny Peter, David W. Dowdy, The Lancet Infectious Diseases Pulmonary TuberculosisClinical EffectivenessHigh RatesEmpirical TreatmentEvidence-based Medicine	2014	154
Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results? Grant Theron, Rouxjeane Venter, Greg Calligaro, Clinical Infectious Diseases	2016	140
Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments Grant Theron, Jonny Peter, Greg Calligaro, Scientific Reports	2014	120
Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid Grant Theron, Jonny Peter, Richard Meldau, Thorax	2013	104
The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria Emek Kocatürk, Andaç Salman, Iván Chérrez-Ojeda, Allergy	2020	88
Psychological distress and its relationship with non-adherence to TB treatment: a multicentre study Grant Theron, Jonny Peter, Lynn S. Zijenah, BMC Infectious Diseases	2015	83

Page 1